Disclosing the Risk Associated with Isolated REM Behavior Disorder: The Sleep Experts’ Perspective

Abstract

AbstractBackgroundIsolated rapid‐eye‐movement sleep behavior disorder (iRBD) is associated with a high risk for phenoconversion to a neurodegenerative disorder, but the optimal approach for disclosure of this risk to patients is still debated.ObjectivesThe aim of this study was to explore views and experiences of iRBD experts regarding risk disclosure.MethodsIn this qualitative study, semi‐structured interviews with sleep experts caring for patients with iRBD were analyzed through a conventional content analysis approach.ResultsWe interviewed 22 iRBD experts (eight female, average age of 51.8 years) from 18 Italian sleep centers; 21/22 regularly disclosed the risks associated with iRBD, usually after the video‐polysomnography, and 8/22 regularly mentioned phenoconversion rates. Content analysis allowed us to identify three main themes. First, sleep experts reported several points in favor of risk disclosure, especially related to the principle of beneficence, but some highlighted the need for specific learning on the topic. Second, experts favored a patient‐tailored disclosure that should not upset the patient unnecessarily, since phenoconversion is uncertain. Third, risk disclosure was seen by participants as a relational task that should be carried out in person in the context of a trusting patient‐physician relationship, while they had contrasting views regarding patients’ previous knowledge.ConclusionsSleep experts generally preferred a tailored and reassuring approach to risk disclosure within a framework of relational autonomy. The results of this study indicate the need for specific education, training, and recommendations concerning risk disclosure that should also include patients’ and families’ preferences.